Moreover, the methylation of the ATP6AP1 promoter was significantly associated with the subtypes and disease stages of BC, especially differing between luminal and triple-negative BC and between stages 1 and 2 (all P < 0.05; Figure 5E and 5F). Here, ATP6AP1 is linked to breast cancer.